Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray-based AMASE as a novel approach for mutation detection.

Max Käller1, Afshin Ahmadian, Joakim Lundeberg

  • 1Department of Biotechnology, The Royal Institute of Technology, AlbaNova University Center, Roslagstullsbacken 21, SE-106 91 Stockholm, Sweden.

Mutation Research
|September 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resolving the Haplotype Complexity of Colorectal Cancer Genomes with Droplet Barcode Sequencing.

Life (Basel, Switzerland)·2026
Same author

Publisher Correction: TGFβ signaling mediates microglial resilience to spatiotemporally restricted myelin degeneration.

Nature neuroscience·2026
Same author

Rare regulatory mutations disrupt mesenchymal molecular programs driving endocardial cushion formation in bicuspid aortic valve.

Nature communications·2026
Same author

Single-cell spatial multi-omics molecular pathology enabled by SuperFocus.

bioRxiv : the preprint server for biology·2026
Same author

Single-Cell and Spatial Transcriptomic Profiling Reveals Epithelial Functional States and Fibroblast Phenotypes in Hormone Therapy-Naïve Localized Prostate Cancer.

Cancer research·2026
Same author

Exploration of immune phenotypes in self-sampling citizens.

iScience·2026
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

This study introduces a novel microarray method for rapid p53 gene re-sequencing and mutation detection. The apyrase-mediated allele-specific extension reaction (AMASE) enables efficient cancer gene scanning.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Alterations in the p53 tumor suppressor gene are critical in human cancer development.
  • Accurate and efficient detection of p53 gene mutations is essential for cancer diagnosis and treatment.

Purpose of the Study:

  • To develop and validate a novel microarray-based approach for re-sequencing and mutation detection of the p53 gene.
  • To assess the utility of apyrase-mediated allele-specific extension reaction (AMASE) for high-throughput genetic analysis.

Main Methods:

  • Development of a microarray platform utilizing allele-specific extension reactions.
  • Application of apyrase-mediated allele-specific extension reaction (AMASE) for in situ DNA extension on a glass slide.
  • Analysis of a 15 bp region in p53 exon 5 and synthetic oligonucleotides to validate mutation detection sensitivity.

Related Experiment Videos

Main Results:

  • The AMASE method demonstrated high accuracy, with a mean allelic fraction of 0.96 for wild-type templates when apyrase was included.
  • The method successfully distinguished between different mutation points using synthetic oligonucleotides.
  • Analysis of skin malignancy samples indicated the potential for comprehensive p53 gene sequencing.

Conclusions:

  • The developed microarray-based AMASE technology offers an efficient and accurate method for p53 gene re-sequencing.
  • This approach has the potential to be expanded for the analysis of other cancer-related genes.
  • AMASE technology provides a promising tool for cancer mutation detection and genetic screening.